• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制剂和辅料对普萘洛尔经皮渗透和滞留的影响。

The Influence of Formulation and Excipients on Propranolol Skin Permeation and Retention.

机构信息

Food and Drug Department, University of Parma, Parco Area delle Scienze 27/a, 43124 Parma, Italy.

出版信息

Biomed Res Int. 2018 Aug 2;2018:1281673. doi: 10.1155/2018/1281673. eCollection 2018.

DOI:10.1155/2018/1281673
PMID:30175113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6098925/
Abstract

The objective of this work was to study propranolol permeation and skin retention after topical application of different semisolid vehicles, with the final aim of developing new topical formulations intended for the treatment of infantile hemangioma, able to produce therapeutic drug levels in the skin, avoiding systemic absorption. Propranolol ointments, creams, and gels were prepared and tested on pig skin, an accepted model of human skin. From the results obtained in the present work it is clear that the permeation of propranolol across the skin is a poor predictor of its skin retention, at least in the time-frame considered. With an application time of 4 h, reasonably close to the permanence time of a semisolid formulation on the skin surface, the best performance (high retention and low skin penetration) was obtained with lipophilic formulations, in particular with a lipophilic cream containing olive oil. Hydrophilic formulations, such as gels, are characterized by a significant permeation across the skin, probably leading to systemic side effects, accompanied by a limited skin retention. Overall, the results obtained in the present work pose the basis for the development of new topical formulations, containing propranolol, with better performance and reduced systemic absorption.

摘要

本工作的目的是研究不同半固体制剂经皮应用后普萘洛尔的渗透和皮肤滞留情况,最终开发出用于治疗婴幼儿血管瘤的新型局部制剂,使药物在皮肤中达到治疗水平,避免全身吸收。制备了普萘洛尔软膏、乳膏和凝胶,并在猪皮上进行了测试,猪皮是人体皮肤的一种公认模型。从本工作获得的结果清楚地表明,普萘洛尔在皮肤中的渗透是其皮肤滞留的不良预测指标,至少在考虑的时间范围内是这样。在 4 小时的应用时间内,与半固体制剂在皮肤表面的停留时间相当接近,最具性能(高保留和低皮肤穿透性)的是脂溶性制剂,特别是含有橄榄油的脂溶性乳膏。亲水制剂,如凝胶,其特点是皮肤穿透性明显,可能导致全身副作用,并伴有有限的皮肤滞留。总的来说,本工作获得的结果为开发具有更好性能和减少全身吸收的新型局部制剂奠定了基础,这些制剂含有普萘洛尔。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6e/6098925/ec57cf42aeac/BMRI2018-1281673.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6e/6098925/07326858c676/BMRI2018-1281673.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6e/6098925/b0179a0b49b7/BMRI2018-1281673.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6e/6098925/ec57cf42aeac/BMRI2018-1281673.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6e/6098925/07326858c676/BMRI2018-1281673.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6e/6098925/b0179a0b49b7/BMRI2018-1281673.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6e/6098925/ec57cf42aeac/BMRI2018-1281673.003.jpg

相似文献

1
The Influence of Formulation and Excipients on Propranolol Skin Permeation and Retention.制剂和辅料对普萘洛尔经皮渗透和滞留的影响。
Biomed Res Int. 2018 Aug 2;2018:1281673. doi: 10.1155/2018/1281673. eCollection 2018.
2
In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions.经皮给药后普罗帕酮载微乳透过完整和微针预处理皮肤的体外滞留和药物渗透。
Pharm Res. 2018 Oct 9;35(12):228. doi: 10.1007/s11095-018-2495-1.
3
Thin polymeric films for the topical delivery of propranolol.用于局部递送普萘洛尔的薄聚合物膜。
Colloids Surf B Biointerfaces. 2019 Feb 1;174:582-586. doi: 10.1016/j.colsurfb.2018.11.022. Epub 2018 Nov 12.
4
Formulation, characterization and clinical evaluation of propranolol hydrochloride gel for transdermal treatment of superficial infantile hemangioma.用于经皮治疗婴幼儿浅表性血管瘤的盐酸普萘洛尔凝胶的制剂、表征及临床评价
Drug Dev Ind Pharm. 2015;41(7):1109-19. doi: 10.3109/03639045.2014.931968. Epub 2014 Aug 25.
5
Formulation study of a patch containing propranolol by design of experiments.采用实验设计研究普萘洛尔贴剂的配方。
Drug Dev Ind Pharm. 2014 Jan;40(1):17-22. doi: 10.3109/03639045.2012.743559. Epub 2013 Jan 10.
6
Formulation of cellulose film containing permeation enhancers for prolonged delivery of propranolol hydrocloride.含渗透促进剂的纤维素膜制剂用于盐酸普萘洛尔的长效递送。
Drug Dev Ind Pharm. 2015 Jun;41(6):1017-25. doi: 10.3109/03639045.2014.925914. Epub 2014 Jun 11.
7
Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery.基于磷脂酰胆碱的胶体系统在皮肤和经皮给药中的应用。
J Liposome Res. 2009;19(4):267-77. doi: 10.3109/08982100902814006.
8
Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.普萘洛尔几种酯类前药的立体选择性经皮转运及同时发生的皮肤水解作用评估:立体选择性渗透机制
Pharm Res. 1996 Oct;13(10):1524-9. doi: 10.1023/a:1016031629845.
9
Crosslinked polyvinylalcohol hydrogels as vehicles for hydrophilic drugs.
Arch Pharm (Weinheim). 2000 Dec;333(12):421-4. doi: 10.1002/1521-4184(200012)333:12<421::aid-ardp421>3.0.co;2-q.
10
Topical Treatment of Infantile Haemangiomas: A Comparative Study on the Selection of a Semi-Solid Vehicle.婴儿血管瘤的局部治疗:半固体载体选择的比较研究
Skin Pharmacol Physiol. 2016;29(4):210-9. doi: 10.1159/000447672. Epub 2016 Aug 18.

引用本文的文献

1
Bioadhesive Eudragit RL100 Nanocapsules for Melanoma Therapy: A Repurposing Strategy for Propranolol.用于黑色素瘤治疗的生物黏附性丙烯酸树脂RL100纳米胶囊:普萘洛尔的一种重新利用策略
Pharmaceutics. 2025 May 29;17(6):718. doi: 10.3390/pharmaceutics17060718.
2
Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas.用于治疗婴儿血管瘤的盐酸普萘洛尔制剂的最新进展
Drug Des Devel Ther. 2025 Feb 18;19:1163-1183. doi: 10.2147/DDDT.S496847. eCollection 2025.
3
Topical beta-blockers in dermatologic therapy.

本文引用的文献

1
Infantile hemangioma: pathogenesis and mechanisms of action of propranolol.婴儿血管瘤:普萘洛尔的发病机制和作用机制。
J Dtsch Dermatol Ges. 2017 Dec;15(12):1185-1190. doi: 10.1111/ddg.13365. Epub 2017 Nov 28.
2
Topical Treatment of Infantile Haemangiomas: A Comparative Study on the Selection of a Semi-Solid Vehicle.婴儿血管瘤的局部治疗:半固体载体选择的比较研究
Skin Pharmacol Physiol. 2016;29(4):210-9. doi: 10.1159/000447672. Epub 2016 Aug 18.
3
Mechanisms of imiquimod skin penetration.咪喹莫特的皮肤渗透机制。
局部用β受体阻滞剂在皮肤科治疗中的应用。
Dermatol Ther. 2021 Jul;34(4):e15016. doi: 10.1111/dth.15016. Epub 2021 Jun 21.
4
Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same.剂型在双氯芬酸经皮给药中的重要性:并非所有双氯芬酸局部用制剂都相同。
J Pain Res. 2019 Apr 12;12:1149-1154. doi: 10.2147/JPR.S191300. eCollection 2019.
Int J Pharm. 2016 Sep 10;511(1):516-523. doi: 10.1016/j.ijpharm.2016.07.043. Epub 2016 Jul 21.
4
Evaluation of β-blocker gel and effect of dosing volume for topical delivery.β受体阻滞剂凝胶的评估及局部给药剂量体积的影响。
J Pharm Sci. 2015 May;104(5):1721-31. doi: 10.1002/jps.24390. Epub 2015 Feb 18.
5
Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.β受体阻滞剂局部给药治疗婴幼儿血管瘤:一项系统评价与荟萃分析。
Ann Plast Surg. 2015 Feb;74(2):256-62. doi: 10.1097/SAP.0000000000000390.
6
Topical propranolol cream in treatment of superficial infantile hemangiomas: a literature review and 4 years of clinical experience.外用普萘洛尔乳膏治疗婴幼儿浅表性血管瘤:文献综述及4年临床经验
Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(4):75-8. doi: 10.15570/actaapa.2014.18.
7
Topical treatment with propranolol gel as a supplement to the existing treatment of hemangiomas.局部使用普萘洛尔凝胶作为现有血管瘤治疗方法的补充。
World J Pediatr. 2014 Nov;10(4):313-7. doi: 10.1007/s12519-014-0509-6. Epub 2014 Dec 17.
8
Formulation, characterization and clinical evaluation of propranolol hydrochloride gel for transdermal treatment of superficial infantile hemangioma.用于经皮治疗婴幼儿浅表性血管瘤的盐酸普萘洛尔凝胶的制剂、表征及临床评价
Drug Dev Ind Pharm. 2015;41(7):1109-19. doi: 10.3109/03639045.2014.931968. Epub 2014 Aug 25.
9
Vehicle influence on permeation through intact and compromised skin.载体对通过完整皮肤和受损皮肤的渗透作用的影响。
Int J Pharm. 2014 Sep 10;472(1-2):362-8. doi: 10.1016/j.ijpharm.2014.06.050. Epub 2014 Jun 27.
10
An insight into the skin penetration enhancement mechanism of N-methylpyrrolidone.N-甲基吡咯烷酮皮肤渗透增强机制的洞察。
Mol Pharm. 2014 Mar 3;11(3):1014-21. doi: 10.1021/mp400675d. Epub 2014 Jan 30.